A Case of Dyspnea Caused by Local Botulinum Toxin Type A Injection |
So, Hoon Sub
(Department of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine)
Moon, Min Young (Department of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine) Lee, Jung Su (Department of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine) Kim, Ho Cheol (Department of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine) Kang, Byung Chul (Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine) Koh, Younsuck (Department of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine) |
1 | International Society of Aesthetic Plastic Surgery. ISAPS International Survey on Aesthetic/Cosmetic Procedurse Performed in 2010 [Internet]. Seoul: ISAPS, c2011 [cited 2012 Oct 30]. Available from: http://www.isaps.org/files/ html-contents/ ISAPS-Procedures-Study-Results-2011.pdf. |
2 | Erbguth FJ. From poison to remedy: the chequered history of botulinum toxin. J Neural Transm 2008;115:559-565. DOI ScienceOn |
3 | ALLERGAN, BOTOX Cosmetic Prescribing Information, in Internet, ALLERGAN, Editor 2011. Avilable from: http:// www.allergan.com/assets/pdf/botox_cosmetic_pi.pdf. |
4 | Sunness JS, Kelman S. Cosmetic botox injection mimicking myasthenia gravis. Plast Reconstr Surg 2004;113:1515. http://dx.doi.org/10.1097/01.PRS.0000118253.77597.9F. |
5 | Turkel CC, Bowen B, Liu J, Brin MF. Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity. Arch Phys Med Rehabil 2006;87: 786-792. DOI ScienceOn |
6 | Naumann M, Jankovic J. Safety of botulinum toxin type A: a systematic review and meta-analysis. Curr Med Res Opin 2004;20:981-990. DOI ScienceOn |
7 | Tacket CO, Shandera WX, Mann JM, Hargrett NT, Blake PA. Equine antitoxin use and other factors that predict outcome in type A foodborne botulism. Am J Med 1984; 76:794-798. DOI ScienceOn |
8 | Arnon SS, Schechter R, Maslanka SE, Jewell NP, Hatheway CL. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med 2006;354:462-471. DOI ScienceOn |
9 | Carruthers JA, Lowe NJ, Menter MA, et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002; 46:840-849. DOI ScienceOn |